Alzheimer’s Disease Assessment Scale–Cognitive subscale variants in mild cognitive impairment and mild Alzheimer’s disease: change over time and the effect of enrichment strategies
出版年份 2016 全文链接
标题
Alzheimer’s Disease Assessment Scale–Cognitive subscale variants in mild cognitive impairment and mild Alzheimer’s disease: change over time and the effect of enrichment strategies
作者
关键词
ADAS-Cog, Enrichment markers, Mild Alzheimer’s disease, Mild cognitive impairment, t-Tau/Aβ ratio, Decline over time
出版物
Alzheimers Research & Therapy
Volume 8, Issue 1, Pages -
出版商
Springer Nature
发表日期
2016-02-09
DOI
10.1186/s13195-016-0170-5
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Cognitive Changes Preceding Clinical Symptom Onset of Mild Cognitive Impairment and Relationship to ApoE Genotype
- (2014) Marilyn Albert et al. Current Alzheimer Research
- New applications of disease genetics and pharmacogenetics to drug development
- (2014) Allen D Roses et al. CURRENT OPINION IN PHARMACOLOGY
- Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria
- (2014) Bruno Dubois et al. LANCET NEUROLOGY
- Designing drug trials for Alzheimer’s disease: What we have learned from the release of the phase III antibody trials: A report from the EU/US/CTAD Task Force
- (2013) Bruno Vellas et al. Alzheimers & Dementia
- Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy
- (2013) Chia-Chen Liu et al. Nature Reviews Neurology
- Fluid Biomarkers in Alzheimer Disease
- (2013) K. Blennow et al. Cold Spring Harbor Perspectives in Medicine
- The Neuropsychological Profile of Alzheimer Disease
- (2013) S. Weintraub et al. Cold Spring Harbor Perspectives in Medicine
- The ADAS-Cog revisited: Novel composite scales based on ADAS-Cog to improve efficiency in MCI and early AD trials
- (2012) Nandini Raghavan et al. Alzheimers & Dementia
- Putting the Alzheimer’s cognitive test to the test I: Traditional psychometric methods
- (2012) Jeremy Hobart et al. Alzheimers & Dementia
- Estimating sample sizes for predementia Alzheimer's trials based on the Alzheimer's Disease Neuroimaging Initiative
- (2012) Joshua D. Grill et al. NEUROBIOLOGY OF AGING
- Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Reisa A. Sperling et al. Alzheimers & Dementia
- Treatment With Cholinesterase Inhibitors and Memantine of Patients in the Alzheimer's Disease Neuroimaging Initiative
- (2011) Lon S. Schneider ARCHIVES OF NEUROLOGY
- The relative efficiency of time-to-threshold and rate of change in longitudinal data
- (2011) M.C. Donohue et al. Contemporary Clinical Trials
- Testing the Right Target and Right Drug at the Right Stage
- (2011) R. A. Sperling et al. Science Translational Medicine
- Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects
- (2009) Leslie M. Shaw et al. ANNALS OF NEUROLOGY
- APOE-4 Genotype and Neurophysiological Vulnerability to Alzheimer's and Cognitive Aging
- (2009) Susan Bookheimer et al. Annual Review of Clinical Psychology
- Biological markers of amyloid β-related mechanisms in Alzheimer's disease
- (2009) Harald Hampel et al. EXPERIMENTAL NEUROLOGY
- Prevalence and prognostic value of CSF markers of Alzheimer's disease pathology in patients with subjective cognitive impairment or mild cognitive impairment in the DESCRIPA study: a prospective cohort study
- (2009) Pieter Jelle Visser et al. LANCET NEUROLOGY
- Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade
- (2009) Clifford R Jack et al. LANCET NEUROLOGY
- Alzheimer's Disease Neuroimaging Initiative (ADNI): Clinical characterization
- (2009) R. C. Petersen et al. NEUROLOGY
- Endpoints for trials in Alzheimer's disease: a European task force consensus
- (2008) Bruno Vellas et al. LANCET NEUROLOGY
- Safety and efficacy of galantamine in subjects with mild cognitive impairment
- (2008) B. Winblad et al. NEUROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started